{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:11:08Z","timestamp":1793373068065,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","award":["453246190"],"award-info":[{"award-number":["453246190"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.ejmech.2026.118624","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T07:54:30Z","timestamp":1770191670000},"page":"118624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2\/IMP2)"],"prefix":"10.1016","volume":"307","author":[{"given":"Aylin","family":"Berwanger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konrad","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Both","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas M.","family":"Kany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyana","family":"Mazlom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna K.H.","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra K.","family":"Kiemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0503-5830","authenticated-orcid":false,"given":"Martin","family":"Empting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2026.118624_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2025.108247","article-title":"Structural insights into IMP2 dimerization and RNA binding","author":"Zorc","year":"2025","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.ejmech.2026.118624_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1530\/rep.1.00664","article-title":"Expression of IGF-II mRNA-binding proteins (IMPs) in gonads and testicular cancer","volume":"130","author":"Hammer","year":"2005","journal-title":"Reproduction"},{"key":"10.1016\/j.ejmech.2026.118624_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/acschembio.1c00833","article-title":"First small-molecule inhibitors targeting the RNA-binding protein IGF2BP2\/IMP2 for cancer therapy","volume":"17","author":"Dahlem","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2026.118624_bib4","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.tem.2020.05.007","article-title":"The diverse functions of IMP2\/IGF2BP2 in metabolism","volume":"31","author":"Dai","year":"2020","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejmech.2026.118624_bib5","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jhep.2010.08.034","article-title":"Overexpression of the IGF2-mRNA binding protein p62 in transgenic mice induces a steatotic phenotype","volume":"54","author":"Tybl","year":"2011","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ejmech.2026.118624_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12943-023-01787-x","article-title":"A combined computational and functional approach identifies IGF2BP2 as a driver of chemoresistance in a wide array of pre-clinical models of colorectal cancer","volume":"22","author":"Kendzia","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejmech.2026.118624_bib7","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.189.7.1101","article-title":"A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma","volume":"189","author":"Zhang","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejmech.2026.118624_bib8","doi-asserted-by":"crossref","first-page":"4440","DOI":"10.1038\/s41467-019-12193-7","article-title":"The structural basis for RNA selectivity by the IMP family of RNA-binding proteins","volume":"10","author":"Biswas","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2026.118624_bib9","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12935-021-01799-x","article-title":"The role of IGF2BP2, an m6A reader gene, in human metabolic diseases and cancers","volume":"21","author":"Wang","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.ejmech.2026.118624_bib10","article-title":"Structural insights into IMP2 dimerization and RNA binding","author":"Zorc","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.ejmech.2026.118624_bib11","doi-asserted-by":"crossref","first-page":"G328","DOI":"10.1152\/ajpgi.00005.2012","article-title":"IGF2 mRNA binding protein p62\/IMP2-2 in hepatocellular carcinoma: antiapoptotic action is independent of IGF2\/PI3K signaling","volume":"304","author":"Kessler","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.ejmech.2026.118624_bib12","doi-asserted-by":"crossref","first-page":"89736","DOI":"10.18632\/oncotarget.21116","article-title":"IMP2\/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer","volume":"8","author":"Kessler","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejmech.2026.118624_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20133204","article-title":"The insulin-like growth factor 2 mRNA binding protein IMP2\/IGF2BP2 is overexpressed and correlates with poor survival in pancreatic cancer","volume":"20","author":"Dahlem","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2026.118624_bib14","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.4103\/jcrt.jcrt_2272_23","article-title":"The m6A reader IGF2BP2 promotes ESCC progression by stabilizing HDGF mRNA","volume":"20","author":"Jia","year":"2024","journal-title":"J. Cancer Res. Therapeut."},{"key":"10.1016\/j.ejmech.2026.118624_bib15","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3389\/fmed.2019.00179","article-title":"IGF2 mRNA binding protein 2 transgenic mice are more prone to develop a ductular reaction and to progress toward cirrhosis","volume":"6","author":"Czepukojc","year":"2019","journal-title":"Front. Med."},{"key":"10.1016\/j.ejmech.2026.118624_bib16","article-title":"Identification of targetable vulnerabilities of PLK1-overexpressing cancers by synthetic dosage lethality","volume":"5","author":"Cunningham","year":"2025","journal-title":"Cell Genom."},{"key":"10.1016\/j.ejmech.2026.118624_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.31083\/j.fbl2901041","article-title":"Gene editing and small molecule inhibitors of the RNA binding protein IGF2BP2\/IMP2 show its potential as an anti-cancer drug target","volume":"29","author":"Chanda","year":"2024","journal-title":"Front. Biosci."},{"key":"10.1016\/j.ejmech.2026.118624_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejmech.2014.02.014","article-title":"Benzamidobenzoic acids as potent PqsD inhibitors for the treatment of Pseudomonas aeruginosa infections","volume":"76","author":"Hinsberger","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118624_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejmech.2015.04.007","article-title":"Exploring the chemical space of ureidothiophene-2-carboxylic acids as inhibitors of the quorum sensing enzyme PqsD from Pseudomonas aeruginosa","volume":"96","author":"Sahner","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2026.118624_bib20","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","volume":"596","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2026.118624_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3762\/bjoc.11.59","article-title":"Metal-free one-pot synthesis of 2-substituted and 2,3-disubstituted morpholines from aziridines","volume":"11","author":"Sun","year":"2015","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118624_bib22","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1039\/D1QO01190A","article-title":"A robust and facile method for desulfonation to amines","volume":"8","author":"Li","year":"2021","journal-title":"Org. Chem. Front."},{"key":"10.1016\/j.ejmech.2026.118624_bib23","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.1021\/ol200740r","article-title":"Ti(O-i-Pr)4\/Me3SiCl\/Mg-mediated reductive cleavage of sulfonamides and sulfonates to amines and alcohols","volume":"13","author":"Shohji","year":"2011","journal-title":"Org. Lett."},{"key":"10.1016\/j.ejmech.2026.118624_bib24","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1021\/jo00334a056","article-title":"Preparation of highly reactive metal powders. New procedure for the preparation of highly reactive zinc and magnesium metal powders","volume":"46","author":"Rieke","year":"1981","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118624_bib25","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/anie.201409283","article-title":"Combining organometallic reagents, the sulfur dioxide surrogate DABSO, and amines: a one-pot preparation of sulfonamides, amenable to array synthesis","volume":"54","author":"Deeming","year":"2015","journal-title":"Angew Chem. Int. Ed. Engl."},{"key":"10.1016\/j.ejmech.2026.118624_bib26","unstructured":"Takeda Pharmaceutical Company Limited WO 2009\/067547 A1, 2009."},{"key":"10.1016\/j.ejmech.2026.118624_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00706-013-1094-4","article-title":"A simple, rapid, and efficient N-Boc protection of amines under ultrasound irradiation and catalyst-free conditions","volume":"145","author":"Amira","year":"2014","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2026.118624_bib28","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1021\/jo000225s","article-title":"New synthesis of 1,1-Substituted hydrazines by alkylation of N-Acyl- or N-alkyloxycarbonylaminophthalimide using the mitsunobu protocol","volume":"65","author":"Brosse","year":"2000","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2026.118624_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1021\/ml3003296","article-title":"Metal impurities cause false positives in high-throughput screening campaigns","volume":"4","author":"Hermann","year":"2013","journal-title":"ACS Med. Chem. Lett."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523426000693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:11:53Z","timestamp":1777529513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523426000693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"alternative-id":["S0223523426000693"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118624","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of a new protein-RNA interaction inhibitor targeting the KH34 region of the insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2\/IMP2)","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2026.118624","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118624"}}